[HTML][HTML] Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai, L Kong… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Controversies about the combination of des-gamma-carboxyprothrombin (DCP) and alpha-
fetoprotein (AFP) for hepatocellular carcinoma diagnosing still exist. Hence, we performed …

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai, L Kong… - Oncotarget, 2017 - europepmc.org
Controversies about the combination of des-gamma-carboxyprothrombin (DCP) and alpha-
fetoprotein (AFP) for hepatocellular carcinoma diagnosing still exist. Hence, we performed …

[PDF][PDF] Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai, L Kong… - pdfs.semanticscholar.org
Controversies about the combination of des-gamma-carboxyprothrombin (DCP) and alpha-
fetoprotein (AFP) for hepatocellular carcinoma diagnosing still exist. Hence, we performed …

[HTML][HTML] Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai, L Kong… - Oncotarget, 2017 - oncotarget.com
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular
carcinoma diagnosing: an update meta-analysis and validation study | Oncotarget Online …

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Controversies about the combination of des-gamma-carboxyprothrombin (DCP) and alpha-
fetoprotein (AFP) for hepatocellular carcinoma diagnosing still exist. Hence, we performed …

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

H Chen, S Chen, S Li, Z Chen, X Zhu, M Dai, L Kong… - Oncotarget, 2017 - oncotarget.com
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular
carcinoma diagnosing: an update meta-analysis and validation study | Oncotarget Online …